 |
 |
| Home | About Us | Management | Products | Investor Relations | News | Contact Us |
 |
 |
|
|
| About Us | ||
Initial operations focused on providing a small but targeted
platform of poly-formulas to the patient that address key
multi-factors in disease processes such as atherosclerosis and
diabetes (as opposed to the single target restrictions placed on
prescription drugs that must focus on one disease factor at a time
such as an HMG reductase inhibitor (Statin) that does not address
the multi-factors of atherosclerosis). The Company's historical
lines of NSPs are: XenaCor, XenaZymePlus and XenaTri. NSP's have
been distributed from the physicians offices under physician care. |
||
In mid 2005 the Company began to formulate NSPs for personal
performance and lifestyle performance products. The Company also
developed new distribution channels for the historical NSPs,
including web site and infomercials. The Company had formulated a
line of body replenishment NSPs, which are designed to eliminate
prescription induced nutrient depletion. To replace these nutrients,
NSPs have been formulated, which the Company believes will combat
the depletion effects of commonly prescribed drugs. Additionally,
the Company has added a nutritional supplement that defends the skin
from the damaging effects of the sun. The Company has the worldwide
rights to both proprietary items. October 30, 2007 XenaCare completed an asset purchase covering certain assets of 2B Healthy, a division of Beta Pharmaceutical Corporation. Beta Pharmaceutical Corporation Is a $190 million pharmaceutical company with home offices in the US and distribution in 14 South American countries. As part of the asset purchase, XenaCare took ownership of several product lines in the B2 Healthy portfolio. This relationship will allow Xenacare immediate distribution in 14 South American countries and increased distribution In the US. |
||
NutraPharma is a biotechnology company that is developing treatments
for adrenomyeloneuropathy, HIV and multiple sclerosis. Cobroxin is
the first opiate and acetaminophen-free pain reliever available as
an over-the-counter formulation clinically proven to treat moderate
to severe (Stage 2) pain. Available in a topical gel that relieves
pain associated with joints, repetitive stress and arthritis, and in
an oral spray that is formulated to relieve lower back pain,
migraines, neck aches, shoulder pain, cramps and neuralgia.
XenaCare a company specializing in the marketing and retail distribution of consumer healthcare products has announced that it has received the exclusive license to market and distribute a cellular cleanse and detoxification product called Zeolite from Mineral Sciences designed as an effective solution for removing heavy metals and toxins from the body. Research has also shown that the product's Ingredients may help reduce Viral repHcation and support healthy blood sugar levels. Additionally, this product improves nutrient absorption, supports immune system function and reduces symptoms of allergies. |
||
|
|
||
|
Copyright © 2000-2009, Xena Care Holdings. All Rights Reserved.
Designed by
Infinet Solutions
|